NCT02887001

Brief Summary

Incomplete information or poorly communicated to the transitional stages of the patient's drug therapy hospitalized cause medication errors. These steps are the admission, transfer within the institution and hospital discharge to home or another institution. The adequacy of the prescription recommendations of good practice is not always optimal. The cost of taking drug therapy and iatrogenic risks preventable drug-related weighs more and more heavily in health spending and in the prolongation of hospitalization or re hospitalization. Clinical pharmacy widely practiced in the Anglo-Saxon countries has demonstrated its effectiveness on these three themes; it seems appropriate to assess this practice in the environment of the French health system.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2011

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
4.2 years until next milestone

First Submitted

Initial submission to the registry

August 24, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 1, 2016

Completed
Last Updated

March 12, 2026

Status Verified

July 1, 2016

Enrollment Period

1.1 years

First QC Date

August 24, 2016

Last Update Submit

March 11, 2026

Conditions

Admitted to Infectiology or Internal Medicine Wards

Keywords

cost studyclinical pharmacist

Outcome Measures

Primary Outcomes (1)

  • Number of prescriptions

    11 weeks

Study Arms (1)

BMO

OTHER
Other: Pharmacist consultation

Interventions

Pharmacist consultationOTHER
BMO

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients admitted in in infectious and tropical diseases unit or the internal medicine unit

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Leguelinel-Blache G, Dubois F, Bouvet S, Roux-Marson C, Arnaud F, Castelli C, Ray V, Kinowski JM, Sotto A. Improving Patient's Primary Medication Adherence: The Value of Pharmaceutical Counseling. Medicine (Baltimore). 2015 Oct;94(41):e1805. doi: 10.1097/MD.0000000000001805.

    PMID: 26469927RESULT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2016

First Posted

September 1, 2016

Study Start

June 1, 2011

Primary Completion

July 1, 2012

Study Completion

July 1, 2012

Last Updated

March 12, 2026

Record last verified: 2016-07